Marisa Vescovo

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Edvardas Danila, Andrei Maryandyshev, Margareth Pretti Dalcolmo et al. · European Respiratory Journal · 2019 · 168 citations · Full text

Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine

Eduardo Abbate, Marisa Vescovo, Marcela Natiello et al. · Journal of Antimicrobial Chemotherapy · 2011 · 129 citations · Full text

Patients with Multidrug-Resistant Tuberculosis Display Impaired Th1 Responses and Enhanced Regulatory T-Cell Levels in Response to an Outbreak of Multidrug-Resistant<i>Mycobacterium tuberculosis</i>M and Ra Strains

Laura Geffner, Noemí Yokobori, Juan I. Basile et al. · Infection and Immunity · 2009 · 69 citations · Full text

T-regulatory Cell, Immune Regulation, Immunology +20

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Onno W. Akkerman, Alena Aleksa, Jan‐Willem C. Alffenaar et al. · International Journal of Infectious Diseases · 2019 · 54 citations · Full text

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

S Koirala, Edvardas Danila, Andrei Mariandyshev et al. · Pulmonology · 2021 · 47 citations · Full text